Home/Filings/4/0001062993-25-013981
4//SEC Filing

Rottinghaus Scott T. 4

Accession 0001062993-25-013981

CIK 0001177648other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:35 PM ET

Size

4.7 KB

Accession

0001062993-25-013981

Insider Transaction Report

Form 4
Period: 2025-08-08
Rottinghaus Scott T.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2025-08-08$6.99/sh2,217$15,49722,590 total
Footnotes (1)
  • [F1]Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1
  • filerCIK 0001942407

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:35 PM ET
Size
4.7 KB